Large clinical trial finds 24 weeks of Ashwagandha well tolerated without liver or kidney injury
New Delhi, Sep 28 (IANS) A large multicentre clinical study published in Frontiers in Medicine found daily administration of a standardised Ashwagandha root extract for 24 weeks was well tolerated with no evidence of treatment‑related hepatic or renal injury, the government said on Monday.